141 related articles for article (PubMed ID: 11998515)
21. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
[TBL] [Abstract][Full Text] [Related]
22. Spasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis.
Roth CR; Glaze LE; Goding GS; David WS
J Voice; 1996 Dec; 10(4):362-7. PubMed ID: 8943140
[TBL] [Abstract][Full Text] [Related]
23. Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia.
Galardi G; Guerriero R; Amadio S; Leocani L; Teggi R; Melloni G; Comi G
Neurol Sci; 2001 Aug; 22(4):303-6. PubMed ID: 11808853
[TBL] [Abstract][Full Text] [Related]
24. Effect of neuromuscular activity on the response to botulinum toxin injections in spasmodic dysphonia.
Wong DL; Adams SG; Irish JC; Durkin LC; Hunt EJ; Charlton MP
J Otolaryngol; 1995 Aug; 24(4):209-16. PubMed ID: 8551532
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
Sulica L; Blitzer A; Brin MF; Stewart CF
Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
[TBL] [Abstract][Full Text] [Related]
26. Treatment of ventricular dysphonia with botulinum toxin.
Kendall KA; Leonard RJ
Laryngoscope; 1997 Jul; 107(7):948-53. PubMed ID: 9217137
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral approach.
García Ruiz PJ; Cenjor Español C; Sanchez Bernardos V; Astarloa R; Sanabria J; García de Yébenes J
Clin Neuropharmacol; 1998; 21(3):196-8. PubMed ID: 9617512
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
[TBL] [Abstract][Full Text] [Related]
29. Factors Associated with Failure of Botulinum Toxin Injection in Adductor Spasmodic Dysphonia.
Zhao K; Guillaud M; Hu A
Ann Otol Rhinol Laryngol; 2020 Oct; 129(10):996-1002. PubMed ID: 32468829
[TBL] [Abstract][Full Text] [Related]
30. Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes.
Mehta RP; Goldman SN; Orloff LA
Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):393-9. PubMed ID: 11296047
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.
Benninger MS; Gardner G; Grywalski C
Arch Otolaryngol Head Neck Surg; 2001 Sep; 127(9):1083-5. PubMed ID: 11556856
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin in the treatment of adductor spasmodic dysphonia.
Thompson AR
J Ark Med Soc; 1994 Jan; 90(8):383-5. PubMed ID: 8175618
[TBL] [Abstract][Full Text] [Related]
33. Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia.
Ludlow CL; Naunton RF; Sedory SE; Schulz GM; Hallett M
Neurology; 1988 Aug; 38(8):1220-5. PubMed ID: 3399071
[TBL] [Abstract][Full Text] [Related]
34. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
Loven JO; Brøndbo K; Ganes T
Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
[TBL] [Abstract][Full Text] [Related]
35. Adductor spasmodic dysphonia: case reports with acoustic analysis following botulinum toxin injection and acupuncture.
Crevier-Buchman L; Laccourreye O; Papon JF; Nurit D; Brasnu D
J Voice; 1997 Jun; 11(2):232-7. PubMed ID: 9181547
[TBL] [Abstract][Full Text] [Related]
36. A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report.
Rontal M; Rontal E; Rolnick M; Merson R; Silverman B; Truong DD
Laryngoscope; 1991 Aug; 101(8):911-4. PubMed ID: 1865744
[TBL] [Abstract][Full Text] [Related]
37. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
[TBL] [Abstract][Full Text] [Related]
38. Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy.
Murry T; Woodson GE
J Voice; 1995 Dec; 9(4):460-5. PubMed ID: 8574315
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
[TBL] [Abstract][Full Text] [Related]
40. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
